Vivos Therapeutics Plans Rights Offering to Raise Capital at Premium to Current Price
VVOS is trading near its 52-week low of $0.515 (5.7% above the low) on light trading volume (0.2× avg).
Summary
Vivos Therapeutics, facing financial distress, announced plans for a rights offering to raise capital, with a proposed exercise price significantly above its current stock price.
Key Events · Financing and Capital Events · VVOS
-
Proposed Rights Offering
Vivos Therapeutics intends to file a registration statement for a rights offering to distribute transferable subscription rights to shareholders as a dividend, aiming to raise additional capital.
-
Premium Exercise Price
The preliminary exercise price for the rights is set at the greater of $1.25 per share or 20% above the market price on the day before the record date, which is a significant premium to the current stock price of $0.5445.
-
Subsequent 'Exploding' Rights
Upon exercise of a right, holders are expected to receive a second nine-month trading right with an even higher expected exercise price (greater of $1.75 per share or 40% above market).
-
Critical Capital Raise
This initiative is crucial for the company, which has a 'going concern' warning and faces Nasdaq delisting risk, to fund operations and general corporate purposes.
Analysis · VVOS · Industrial Applications And Services
Vivos Therapeutics, a company facing significant financial challenges including a 'going concern' warning and Nasdaq non-compliance, announced its intention to pursue a rights offering. This move is critical for securing additional capital to fund operations. While the offering is still subject to regulatory approval and other conditions, the proposed exercise price of at least $1.25 per share (or 20% above market) is a notable premium to the current stock price of $0.5445, suggesting an attempt to raise funds at a higher valuation. This strategy aims to provide existing shareholders an opportunity to participate and potentially mitigate dilution at current market levels, which is a more favorable approach than a deeply discounted offering.
At the time of this filing, VVOS was trading at $0.54 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.6M. The 52-week trading range was $0.52 to $7.95. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.